Mayo finds convalescent plasma safe for diverse patients with COVID-19

ROCHESTER, Minn. - Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings -- from the U.S. Food and Drug Administration's Expanded Access Program for COVID-19 -- are reported in Mayo Clinic Proceedings. The safety report assessed the seven days following [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news